The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended 3 biosimilars and new indications for reference biologics, moving them closer to final European ...

Potential signal: <li /> I am a seller of this pair, right here, right now. <li /> I would have a stop loss at 1.0510 and would be aiming for a ...

Shanghai Henlius Biotech, Inc. (2696.HK) today announced it has entered into a license agreement with Dr. Reddy's Laboratories SA, wholly-owned subsidiary of Dr. Reddy's Laboratories Ltd., (BSE: ...

GBP/USD halts its three-day winning streak, trading around 1.2490 during the Asian hours on Thursday. The Pound Sterling ...

AUD/USD has found fresh buyers and looks to regain the 0.6300 mark early Friday. A subuded US Dollar performance aids the ...

Valneva’s chikungunya vaccine Ixchiq has been greenlit by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) ...

Thirty patients have received the gene therapy within a clinical trial and early-access program, and the foundation also hopes to seek approval in the US.

Accomplished Leader to Oversee Quality and Compliance Across AIML's Global Operations▪ Strengthens AIML's Commitment to Providing Reliable and Innovative AI-Powered Healthcare Solutions VANCOUVER, BC ...

Request To Download Free Sample of This Strategic Report @ Highlighted with 33 tables and 60 figures, this 119-page report Europe Pharmacovigilance and Drug Safety Software Market 2021-2031 by ...

The CHMP recommends approval for JNJ's subcutaneous formulation of Rybrevant in NSCLC and AstraZeneca's Imfinzi in limited-stage small-cell lung cancer.

EMA committee recommends extension of marketing authorisation for Janssen-Cilag’s subcutaneous Rybrevant to treat advanced EGFR-mutated NSCLC: Beerse, Belgium Tuesday, February ...

The two products, both manufactured by Amgen, are aflibercept biosimilars Pavblu and Skojoy. Both biosimilars are indicated ...